TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 40 filers reported holding TENAX THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $20,000 | – | 10,142 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,108,593 | $3,636,000 | 1.53% |
| ARMISTICE CAPITAL, LLC | 990,000 | $3,247,000 | 1.16% |
| RA Capital Management | 2,389,700 | $7,838,000 | 0.78% |
| Opaleye Management Inc. | 540,000 | $1,771,000 | 0.74% |
| SABBY MANAGEMENT, LLC | 2,693,537 | $8,835,000 | 0.49% |
| Broadfin Capital, LLC | 1,968,631 | $6,457,000 | 0.40% |
| DAFNA Capital Management LLC | 79,509 | $261,000 | 0.23% |
| BOURGEON CAPITAL MANAGEMENT LLC | 55,500 | $182,000 | 0.12% |
| BAILARD, INC. | 60,000 | $197,000 | 0.09% |
| Verition Fund Management LLC | 32,140 | $105,000 | 0.02% |